Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Simulations Plus Inc SLP

Healthcare Medical Devices
Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. Its segments include software and services. It offers 12 software products for pharmaceutical research and development: GastroPlus, DDDPlus... see more

Recent & Breaking News (NDAQ:SLP)

Simulations Plus to Present at the LD MICRO Conference in Los Angeles on December 3

Business Wire November 24, 2014

Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2014 Earnings Release and Conference Call

Business Wire November 18, 2014

Simulations Plus Announces Changes in Board of Directors

Business Wire November 5, 2014

Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share

Business Wire October 28, 2014

Dow Chemical Licenses Simulations Plus Software to Assist with Toxicology and Environmental Research

Business Wire October 27, 2014

Simulations Plus Adds to Portfolio with Release of MembranePlus

Business Wire October 21, 2014

Simulations Plus Wins Cooperative Agreement with FDA

Business Wire September 15, 2014

Company Profile for Simulations Plus, Inc.

Business Wire September 5, 2014

Simulations Plus Reports Preliminary Revenues for Fourth Fiscal Quarter FY2014

Business Wire September 4, 2014

Simulations Plus Closes Acquisition of Cognigen Corporation

Business Wire September 2, 2014

Simulations Plus Releases GastroPlus Version 8.6

Business Wire August 26, 2014

Simulations Plus Releases ADMET Predictor Version 7.1

Business Wire August 5, 2014

Simulations Plus Announces Quarterly Cash Dividend

Business Wire July 25, 2014

Simulations Plus Provides Additional Details Regarding Cognigen Acquisition

Business Wire July 24, 2014

Simulations Plus to Acquire Cognigen Corporation

Business Wire July 23, 2014

Simulations Plus Sets Date for 3rd Quarter 2014 Earnings Release and Conference Call

Business Wire July 3, 2014

Simulations Plus Reports Third Quarter FY2014 Financial Results

Business Wire July 3, 2014

U.S. Environmental Protection Agency Purchases Multiple Licenses of Simulations Plus Software

Business Wire July 2, 2014

Simulations Plus Reports Preliminary Revenues for Third Fiscal Quarter FY2014

Business Wire June 3, 2014

Simulations Plus Releases MedChem Studio Version 4.0 and MedChem Designer 3.0

Business Wire May 22, 2014